BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17824620)

  • 21. Identification of oxygen nucleophiles in tetrahedral intermediates: 2H and 18O induced isotope shifts in 13C NMR spectra of pepsin-bound peptide ketone pseudosubstrates.
    Schmidt PG; Holladay MW; Salituro FG; Rich DH
    Biochem Biophys Res Commun; 1985 Jun; 129(2):597-602. PubMed ID: 3925948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Synthesis of new chromogenic substrates for aspartyl proteases].
    Litvinova OV; Balandina GN; Stepanov VM
    Bioorg Khim; 1998 Jan; 24(1):10-5. PubMed ID: 9551195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH stability of the stromelysin-1 catalytic domain and its mechanism of interaction with a glyoxal inhibitor.
    Howe N; Ceruso M; Spink E; Malthouse JP
    Biochim Biophys Acta; 2011 Oct; 1814(10):1394-403. PubMed ID: 21782982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of activity of aspartic proteinases by cleavage of new chromogenic substrates].
    Litvinova OV; Balandina GN; Stepanov VM
    Bioorg Khim; 1998 Mar; 24(3):175-8. PubMed ID: 9612558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis.
    Hong L; Tang J
    Biochemistry; 2004 Apr; 43(16):4689-95. PubMed ID: 15096037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of a novel pepsin inhibitor from Coriolus versicolor and its biochemical properties.
    Zhang GQ; Zhang QP; Sun Y; Tian YP; Zhou ND
    J Food Sci; 2012 Mar; 77(3):C293-7. PubMed ID: 22384953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the stabilization of tetrahedral adducts by trypsin and delta-chymotrypsin.
    Finucane MD; Malthouse JP
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):889-900. PubMed ID: 1417749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
    Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
    Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonspecific electrostatic binding of substrates and inhibitors to porcine pepsin.
    Kuzmic P; Sun CQ; Zhao ZC; Rich DH
    Adv Exp Med Biol; 1991; 306():75-86. PubMed ID: 1812761
    [No Abstract]   [Full Text] [Related]  

  • 30. The electrostatic driving force for nucleophilic catalysis in L-arginine deiminase: a combined experimental and theoretical study.
    Li L; Li Z; Wang C; Xu D; Mariano PS; Guo H; Dunaway-Mariano D
    Biochemistry; 2008 Apr; 47(16):4721-32. PubMed ID: 18366187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure of a synthetic pepsin inhibitor complexed with endothiapepsin.
    Cooper J; Foundling S; Hemmings A; Blundell T; Jones DM; Hallett A; Szelke M
    Eur J Biochem; 1987 Nov; 169(1):215-21. PubMed ID: 3119339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ¹H, ¹³C, and ¹⁵N backbone resonance assignments of the porcine pepsin and porcine pepsin complexed with pepstatin.
    Horimoto Y; Wang S; Yada RY
    Biomol NMR Assign; 2014 Apr; 8(1):57-61. PubMed ID: 23264006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The thiolase reaction mechanism: the importance of Asn316 and His348 for stabilizing the enolate intermediate of the Claisen condensation.
    Meriläinen G; Poikela V; Kursula P; Wierenga RK
    Biochemistry; 2009 Nov; 48(46):11011-25. PubMed ID: 19842716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of human pepsin and its complex with pepstatin.
    Fujinaga M; Chernaia MM; Tarasova NI; Mosimann SC; James MN
    Protein Sci; 1995 May; 4(5):960-72. PubMed ID: 7663352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 15N nuclear magnetic resonance studies of acid-base properties of pyridoxal-5'-phosphate aldimines in aqueous solution.
    Sharif S; Huot MC; Tolstoy PM; Toney MD; Jonsson KH; Limbach HH
    J Phys Chem B; 2007 Apr; 111(15):3869-76. PubMed ID: 17388551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of hydrogen bonds in the "catalytic triad" of trypsin by NMR spectra at 1H, 13C, and 15N nuclei].
    Golubeb NS; Gindin VA; Ligaĭ SS; Smirnov SN
    Biokhimiia; 1994 May; 59(5):613-24. PubMed ID: 8043688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new lysine derived glyoxal inhibitor of trypsin, its properties and utilization for studying the stabilization of tetrahedral adducts by trypsin.
    Cleary JA; Malthouse JPG
    Biochem Biophys Rep; 2016 Mar; 5():272-284. PubMed ID: 28955834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic studies on the mechanism of pepsin action.
    Silver MS; Stoddard M
    Biochemistry; 1975 Feb; 14(3):614-21. PubMed ID: 234250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Conserved interactions of the active carboxyls in pepsin-like enzymes and retroviral proteases].
    Andreeva NS; Popov ME
    Mol Biol (Mosk); 2002; 36(5):939-44. PubMed ID: 12391858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural and mechanistic insight into the inhibition of aspartic proteases by a slow-tight binding inhibitor from an extremophilic Bacillus sp.: correlation of the kinetic parameters with the inhibitor induced conformational changes.
    Dash C; Phadtare S; Deshpande V; Rao M
    Biochemistry; 2001 Sep; 40(38):11525-32. PubMed ID: 11560501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.